Drug class in one race
Cardiac myosin (inhibitor) drugs for Heart Failure
2 tracked Cardiac myosin (inhibitor) drugs in the Heart Failure race. The class explanation lives on the Cardiac myosin (inhibitor) page; the full indication pipeline across every mechanism is on the Heart Failure page.
1 approved / phase 41 Phase 2
Head-to-head evidence: BMS-986435 vs Mavacamten